Terns Pharmaceuticals (TERN.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec11

Citizens Jmp Raises Terns Pharmaceuticals' Target Price to $57.00

14:11

Dec10

Terns Pharmaceuticals Inc prices public offering at $40 per share

04:32

Dec9

Terns Pharmaceuticals Announces $400 Million IPO

11:23

Dec8

Terns Pharmaceuticals treatment safety remains stable with extended treatment duration

20:54

Terns Pharmaceuticals' TERN-701 Phase I Trial Shows Positive Results in Patients with Chronic Myeloid Leukemia

19:45

Nov23

BMO Analyst Raises Terns Pharmaceuticals Price Target to $30

12:23

Schedules & Filings

Schedules

Filings

Nov10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -24.64 M, EPS -0.2686

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -24.09 M, EPS -0.263

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -23.91 M, EPS -0.2613

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change